A detailed history of Soa Wealth Advisors, Llc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Soa Wealth Advisors, Llc. holds 3,903 shares of BMY stock, worth $156,354. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,903
Previous 4,025 3.03%
Holding current value
$156,354
Previous $206,000 2.43%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

SELL
$47.98 - $54.4 $5,853 - $6,636
-122 Reduced 3.03%
3,903 $211,000
Q4 2023

Jan 10, 2024

SELL
$48.48 - $57.85 $727 - $867
-15 Reduced 0.37%
4,025 $206,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $41,796 - $46,735
722 Added 21.76%
4,040 $234,000
Q2 2023

Jul 07, 2023

BUY
$63.71 - $70.74 $1,274 - $1,414
20 Added 0.61%
3,318 $212,000
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $1,182 - $1,341
18 Added 0.55%
3,298 $228,000
Q4 2022

Jan 10, 2023

BUY
$68.48 - $81.09 $890 - $1,054
13 Added 0.4%
3,280 $0
Q3 2022

Oct 07, 2022

BUY
$0.13 - $76.84 $26 - $15,598
203 Added 6.63%
3,267 $232,000
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $25,707 - $28,312
354 Added 13.06%
3,064 $235,000
Q1 2022

Apr 07, 2022

BUY
$61.48 - $73.72 $860 - $1,032
14 Added 0.52%
2,710 $197,000
Q4 2021

Jan 13, 2022

SELL
$53.63 - $62.52 $43,601 - $50,828
-813 Reduced 23.17%
2,696 $168,000
Q3 2021

Oct 12, 2021

BUY
$59.17 - $69.31 $61,063 - $71,527
1,032 Added 41.66%
3,509 $207,000
Q2 2021

Jul 14, 2021

SELL
$61.91 - $67.42 $14,548 - $15,843
-235 Reduced 8.67%
2,477 $165,000
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $771 - $867
-13 Reduced 0.48%
2,712 $171,000
Q4 2020

Mar 10, 2021

BUY
$57.74 - $65.43 $157,341 - $178,296
2,725 New
2,725 $163,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Soa Wealth Advisors, Llc. Portfolio

Follow Soa Wealth Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soa Wealth Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Soa Wealth Advisors, Llc. with notifications on news.